ONO PHARMACEUTICAL CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,198 JPY | -2.14% |
|
-4.68% | -12.64% |
| 04-30 | Japan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansion | RE |
| 04-29 | US Equity Markets Close Higher Monday Ahead of Earnings, Fed Meeting This Week | MT |
| Sales 2024 | 503B 3.2B 251B | Sales 2025 * | 472B 3.01B 236B | Capitalization | 1,055B 6.72B 527B |
|---|---|---|---|---|---|
| Net income 2024 | 128B 816M 63.99B | Net income 2025 * | 99.21B 632M 49.6B | EV / Sales 2024 | 2.29 x |
| Net cash position 2024 * | 146B 928M 72.77B | Net cash position 2025 * | 191B 1.22B 95.66B | EV / Sales 2025 * | 1.83 x |
| P/E ratio 2024 |
9.21
x | P/E ratio 2025 * |
10.7
x | Employees | 3,761 |
| Yield 2024 |
3.26% | Yield 2025 * |
3.56% | Free-Float | 75.9% |
More Fundamentals
* Assessed data
More news
Latest transcript on Ono Pharmaceutical Co., Ltd.
More recommendations
More press releases
More news
| 1 day | -2.14% | ||
| 1 week | -4.68% | ||
| Current month | -3.43% | ||
| 1 month | -3.43% | ||
| 3 months | -10.76% | ||
| 6 months | -21.85% | ||
| Current year | -12.64% |
1 week
2 156.00
2 316.50
1 month
2 156.002 391.00
Current year
2 156.002 777.00
1 year
2 156.002 966.50
3 years
2 156.003 990.00
5 years
1 841.003 990.00
10 years
1 542.005 880.00
| Managers | Title | Age | Since |
|---|---|---|---|
Gyo Sagara
CEO | Chief Executive Officer | 65 | 31/03/83 |
Toichi Takino
PSD | President | 55 | - |
| Director/Board Member | 64 | 31/03/85 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Isao Ono
BRD | Director/Board Member | 65 | 31/03/81 |
Shusaku Nagae
BRD | Director/Board Member | 74 | - |
| Director/Board Member | 64 | 31/03/85 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 3.23% | 19 M€ | +10.73% | ||
| 0.67% | 240 M€ | +17.47% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 27/05/24 | 2,198 | -2.14% | 2 459 900 |
| 24/05/24 | 2,246 | -1.14% | 1,290,200 |
| 23/05/24 | 2,272 | +0.96% | 1,369,000 |
| 22/05/24 | 2,250 | -1.72% | 1,533,100 |
| 21/05/24 | 2,290 | -0.69% | 1,552,200 |
Delayed Quote Japan Exchange, May 27, 2024 at 07:00 am
More quotes
ONO PHARMACEUTICAL CO., LTD. is a Japan-based company primarily engaged in the manufacture and sale of pharmaceuticals. The Company operates in one business segment. The Pharmaceutical segment involves in the manufacture and sale of drugs for medical and general use. The Company also involves in the clinical development, introduction and derivation of pharmaceuticals.
Sector
Pharmaceuticals
Calendar
28/07/2024
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
HOLD
Number of Analysts
12
Last Close Price
2,246
JPY
Average target price
2,639
JPY
Spread / Average Target
+17.51%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -12.64% | 6.72B | |
| +16.61% | 42.95B | |
| +16.32% | 21.38B | |
| +19.66% | 15.05B | |
| +18.59% | 14.45B | |
| +53.90% | 13.04B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +11.21% | 5.47B | |
| +7.31% | 4.84B |
- Stock Market
- Equities
- 4528 Stock
